ANDA 209873, held by Penn Life. Arsenic Trioxide.
As of Nov 15, 2026, ANDA 209873 (Arsenic Trioxide), held by Penn Life, was first approved by FDA on May 6, 2019, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 6, 2019 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Arsenic Trioxide1MG/ML ยท injectable;injection | Arsenic Trioxide | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
